Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Dare Bioscience, Inc. (DARE) had Debt to Equity Ratio of 0.53 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.02M |
|
$-1.44M |
|
-- |
|
$1.02M |
|
$2.49M |
|
$-1.47M |
|
$0.03M |
|
$-1.44M |
|
$-1.44M |
|
$-1.44M |
|
$-1.44M |
|
$-1.44M |
|
$-1.44M |
|
$-1.47M |
|
$-1.07M |
|
11.18M |
|
11.18M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$27.06M |
|
$1.56M |
|
$5.41M |
|
$32.47M |
|
$23.69M |
|
-- |
|
$5.95M |
|
$29.63M |
|
$2.84M |
|
$2.84M |
|
$2.84M |
|
14.50M |
|
| Cash Flow Statement Financials | |
$-9.89M |
|
$-0.39M |
|
$19.28M |
|
$16.00M |
|
$25.01M |
|
$9.01M |
|
$1.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.14 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.53 |
71.10% |
|
-143.72% |
|
-143.72% |
|
-- |
|
-140.84% |
|
-140.84% |
|
$-10.27M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-50.72% |
|
-50.72% |
|
-4.44% |
|
-50.72% |
|
$0.20 |
|
$-0.92 |
|
$-0.88 |
|